Publication | Closed Access

Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation

Neurodegenerative DiseasesCognitive DysfunctionNeuropharmacologyNeurochemical BiomarkersNeuroprotectionNeurologyNeuroscienceBrain PathologyMedicineProtective Effect